EUVIMEDEUVIMED entdecken
Open Access · CC BY 2.0

Cardiac-derived CTRP9 mediates the protection of empagliflozin against diabetes-induced male subfertility in mice

Yang Mu, Ling-Bo Luo, Rong Huang, Zhuo-Yu Shen, Dan Huang, Shu-Hong Zhao, Jing Yang, Zhen-Guo Ma iD

Clinical Science · 06.11.2024 · 138 (21) · 1421-1440

DOI: 10.1042/cs20241477 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Science, online erschienen am 04.11.2024. Verfasst von Yang Mu und 7 weiteren Autor:innen. Beteiligte Einrichtung: Reproductive Medicine Center, Renmin Hospital of Wuhan University, Wuhan 430060, China. Hauptthemen laut MEDLINE: Benzhydryl Compounds, Diabetes Mellitus, Experimental, Glucosides, Infertility, Male. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 69 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 2.0). Gefördert von: National Natural Science Foundation of China (NSFC).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Previous studies have shown beneficial effects of empagliflozin (Empa), a selective inhibitor of the sodium-glucose cotransporter 2 (SGLT2), on diabetes and cardiovascular outcomes in patients with diabetes. However, whether Empa could ameliorate diabetes mellitus (DM)-induced male spermatogenesis dysfunction remains unclear. Our study aimed to investigate the effect of Empa in the development of DM-induced male spermatogenesis dysfunction and to reveal the molecular mechanisms. DM mice were orally treated with Empa to investigate the effects of Empa on DM-induced male mice spermatogenesis dysfunction. We employed a cardiac-specific C1q/tumor necrosis factor-related protein 9 (CTRP9)-deficient mouse model and a cardiac-specific CTRP9 overexpression mouse model to investigate its role in the protection of Empa against diabetes-induced male subfertility. We found that Empa treatment could improve DM-induced male mice subfertility. Interestingly, we discovered that cardiac-derived CTRP9 was decreased in DM mice and this decrease was prevented by Empa treatment. A CTRP9 blocking antibody or cardiac-specific depletion of CTRP9 abolished the protection of Empa on DM-induced male subfertility. Cardiac-specific CTRP9 overexpression ameliorated DM-induced male subfertility. Mechanistically, we identified that cardiac-derived CTRP9 increased steroidogenesis in mice with diabetes in a PKA-dependent manner. We also provided direct evidence that activation of AMP activated protein kinase α (AMPKα)/nuclear factor (erythroid-derived 2)-like 2 (Nrf2) signalling pathway by CTRP9 was responsible for the attenuation of ferroptosis in Leydig cells. In conclusions, we supposed that Empa was a potential therapeutic agent against DM-induced male mice spermatogenesis dysfunction.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Benzhydryl CompoundsDiabetes Mellitus, ExperimentalGlucosidesInfertility, MaleSodium-Glucose Transporter 2 InhibitorsSpermatogenesisAnimalsMaleMiceAdiponectinAMP-Activated Protein KinasesMice, Inbred C57BLMice, KnockoutMyocardiumSignal TransductionGlycoproteins

Stichwörter der Autor:innen

CTRP9Empagliflozinspermatogenesis dysfunction

Substanzen

AdiponectinAMP-Activated Protein KinasesBenzhydryl CompoundsGlucosidesSodium-Glucose Transporter 2 InhibitorsCTRP9 protein, mouseGlycoproteinsempagliflozin

Autor:innen und Institutionen

  • Reproductive Medicine Center, Renmin Hospital of Wuhan University, Wuhan 430060, China.
  • Department of Cardiology, Renmin Hospital of Wuhan University, Wuhan 430060, China.
  • Hubei Key Laboratory of Metabolic and Chronic Diseases, Wuhan 430060, China.

ORCID-Profile: Zhen-Guo Ma

Förderung

  • National Natural Science Foundation of China (NSFC)

Zitieren

APA

Mu, Y., Luo, L. B., Huang, R., Shen, Z. Y., Huang, D., Zhao, S. H., Yang, J., & Ma, Z. G. (2024). Cardiac-derived CTRP9 mediates the protection of empagliflozin against diabetes-induced male subfertility in mice. Clinical Science, 138(21), 1421-1440. https://doi.org/10.1042/cs20241477

Vancouver

Mu Y, Luo LB, Huang R, Shen ZY, Huang D, Zhao SH, et al. Cardiac-derived CTRP9 mediates the protection of empagliflozin against diabetes-induced male subfertility in mice. Clinical Science. 2024;138(21):1421-1440. doi:10.1042/cs20241477

BibTeX
@article{Mu2024,
  author = {Mu, Yang and Luo, Ling-Bo and Huang, Rong and Shen, Zhuo-Yu and Huang, Dan and Zhao, Shu-Hong and Yang, Jing and Ma, Zhen-Guo},
  title = {Cardiac-derived CTRP9 mediates the protection of empagliflozin against diabetes-induced male subfertility in mice},
  journal = {Clinical Science},
  year = {2024},
  volume = {138},
  number = {21},
  pages = {1421--1440},
  doi = {10.1042/cs20241477}
}
Kostenlos starten →